Li F - Search Results

1

Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies.

Zhao Y, Chen P, Dou L, Li F, Li M, Xu L, Chen J, Jia M, Huang S, Wang N, Luan S, Yang J, Bai N, Liu D. Zhao Y, et al. Among authors: li f, li m. Drug Des Devel Ther. 2022 Mar 25;16:817-825. doi: 10.2147/DDDT.S354270. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35370398 Free PMC article. Clinical Trial.

2

Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial.

Dou L, Peng B, Li X, Wang L, Jia M, Xu L, Li F, Liu D. Dou L, et al. Among authors: li f, li x. Trials. 2022 Jun 6;23(1):470. doi: 10.1186/s13063-022-06426-2. Trials. 2022. PMID: 35668528 Free PMC article.

3

Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy.

Yang J, Peng B, Wang L, Li X, Li F, Jin X, Jia M, Xu L, Dou L, Liu D. Yang J, et al. Among authors: li f, li x. Ann Hematol. 2022 Mar;101(3):621-630. doi: 10.1007/s00277-021-04727-1. Epub 2021 Nov 23. Ann Hematol. 2022. PMID: 34816294 Free PMC article. Clinical Trial.

4

High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors.

Wang N, Wang H, Fang S, Du J, Huang S, Li F, Jin X, Jia M, Xu L, Dou L, Liu D. Wang N, et al. Among authors: li f. Transplant Cell Ther. 2022 Nov;28(11):769.e1-769.e9. doi: 10.1016/j.jtct.2022.08.012. Epub 2022 Aug 13. Transplant Cell Ther. 2022. PMID: 35973670 Free article.

5

Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.

Yan F, Lu N, Gu Z, Huang W, Wang S, Gao X, Dou L, Li F, Wang L, Li M, Liu D, Gao C. Yan F, et al. Among authors: li f, li m. Ann Hematol. 2022 Feb;101(2):397-408. doi: 10.1007/s00277-021-04706-6. Epub 2021 Nov 4. Ann Hematol. 2022. PMID: 34735613

6

Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation.

Wang H, Zhao Y, Fang S, Wang L, Peng B, Yang J, Wang N, Du J, Li F, Jin X, Luan S, Wu X, Dou L, Liu D. Wang H, et al. Among authors: li f. Transplant Cell Ther. 2022 Jun;28(6):332.e1-332.e10. doi: 10.1016/j.jtct.2022.03.018. Epub 2022 Mar 18. Transplant Cell Ther. 2022. PMID: 35314377 Free article.

7

Ruxolitinib Combined with Corticosteroids as First-Line Therapy for Acute Graft-versus-Host Disease in Haploidentical Peripheral Blood Stem Cell Transplantation Recipients.

Hou C, Dou L, Jia M, Li F, Wang S, Gao X, Wang L, Jin X, Wang L, Gao C, Liu D. Hou C, et al. Among authors: li f. Transplant Cell Ther. 2021 Jan;27(1):75.e1-75.e10. doi: 10.1016/j.bbmt.2020.09.015. Epub 2020 Sep 19. Transplant Cell Ther. 2021. PMID: 32961370 Free article.

8

The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.

Gu Z, Xiong Q, Wang L, Wang L, Li F, Hou C, Dou L, Zhu B, Liu D. Gu Z, et al. Among authors: li f. Cancer. 2022 Apr 1;128(7):1402-1410. doi: 10.1002/cncr.34091. Epub 2022 Jan 25. Cancer. 2022. PMID: 35077579 Free article.

9

Increased risk of nonrelapse mortality post T-cell-replete haploidentical stem cell transplantation in patients with recurrence of acute graft-versus-host disease.

Peng B, Dou L, Yang J, Wang L, Li F, Gao X, Wang S, Jin X, Wang L, Jia M, Wang S, Li Y, Liu D. Peng B, et al. Among authors: li f, li y. Hematol Oncol. 2022 Oct;40(4):743-751. doi: 10.1002/hon.2999. Epub 2022 Apr 17. Hematol Oncol. 2022. PMID: 35385135

10

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Dou LP, Li HH, Wang L, Li F, Huang WR, Yu L, Liu DH. Dou LP, et al. Among authors: li hh, li f. Chin Med J (Engl). 2018 Apr 5;131(7):790-798. doi: 10.4103/0366-6999.228243. Chin Med J (Engl). 2018. PMID: 29578122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,299 results

Search Page

Filters